In vitro equivalence assessment of rivaroxaban tablets
Background. Thrombotic conditions and complicationsa are among the leading causes of death and disability in high-income countries. The introduction of direct oral anticoagulants into clinical practice has expanded the possibilities of anticoagulant therapy. Having a broader spectrum of indications...
Spremljeno u:
| Glavni autori: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Russo |
| Izdano: |
ZAO "Consilium Medicum"
2025-01-01
|
| Serija: | Consilium Medicum |
| Teme: | |
| Online pristup: | https://consilium.orscience.ru/2075-1753/article/viewFile/698700/217976 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|